Work

Phase II trial of tesetaxel, an oral taxane, as second-line therapy for patients with advanced gastroesophageal cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4077

Authors: Mary Frances Mulcahy, Jackie S. Baker, Weijing Sun, Sun Young Rha, Hassan Danesi, Loretta Itri, Jaffer A. Ajani

Institutions: Northwestern University, The University of Texas MD Anderson Cancer Center, Abramson Cancer Center, University of Pennsylvania, Yonsei University, Severance Hospital

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601262980

Cites:

Cited by: 1

Related to: 10